Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
暂无分享,去创建一个
M. Pfisterer | P. Buser | H. Brunner-La Rocca | P. Rickenbacher | Hans Peter Brunner-La Rocca | Alain Bernheim | Matthias Pfisterer | Peter Rickenbacher | A. Bernheim | Ruth Schindler | Peter Theo Buser | R. Schindler
[1] M. Pahor,et al. Hypotension and cognitive impairment , 2001, Neurology.
[2] J. Pell,et al. Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.
[3] C. Frampton,et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.
[4] J. Sanderson,et al. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. , 2003, The American journal of cardiology.
[5] L. Fisher,et al. Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) , 2003, Circulation.
[6] M A Hlatky,et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). , 1989, The American journal of cardiology.
[7] H. Ni. Prevalence of self-reported heart failure among US adults: results from the 1999 National Health Interview Survey. , 2003, American heart journal.
[8] S. Willich,et al. Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease , 2003, Heart.
[9] Elizabeth H Bradley,et al. Understanding the treatment preferences of seriously ill patients. , 2002, The New England journal of medicine.
[10] Harlan M. Krumholz,et al. The Burden of Chronic Congestive Heart Failure in Older Persons: Magnitude and Implications for Policy and Research , 2004, Heart Failure Reviews.
[11] L. Stevenson,et al. Preferences for quality of life or survival expressed by patients with heart failure. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[12] K. Bailey,et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. , 1998, Circulation.
[13] T. Fukutomi,et al. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction. , 2004, The American journal of cardiology.
[14] Harlan M Krumholz,et al. Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.
[15] F. Zannad,et al. Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers. , 2004, Journal of the American College of Cardiology.
[16] J. Cohn,et al. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. , 1993, The American journal of cardiology.
[17] M. Rich,et al. Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. , 1997, The American journal of cardiology.
[18] C. Camargo,et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. , 2005, The American journal of cardiology.
[19] J. Gottdiener,et al. Congestive heart failure in the elderly: the Cardiovascular Health Study. , 2004, The American journal of geriatric cardiology.
[20] A. Abdelhafiz,et al. Heart failure in older people: causes, diagnosis and treatment. , 2002, Age and ageing.
[21] Douglas W Mahoney,et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.
[22] William D. Dupont,et al. Power and sample size calculations. A review and computer program. , 1990, Controlled clinical trials.
[23] M. Kodama,et al. Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart. , 2000, Journal of cardiovascular pharmacology.
[24] H. Krumholz,et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. , 2001, Journal of the American College of Cardiology.
[25] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[26] L. Goldman,et al. Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. , 1998, Circulation.
[27] H. Krum,et al. Demographics and concomitant disorders in heart failure , 2003, The Lancet.
[28] Simon Capewell,et al. The current cost of heart failure to the National Health Service in the UK , 2002, European journal of heart failure.
[29] K. Swedberg,et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. , 2004, European heart journal.
[30] M. Davies,et al. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. , 2002, European heart journal.